Relmada Therapeutics Inc
F:4E2
Relmada Therapeutics Inc
F:4E2
Kurs:
5,25
EUR
8,92%
Markt geschlossen
Marktkap.:
€158,02 Mio.
Notiz hinzufügen
Kursziel hinzufügen
Gedanken festhalten und ein Kursziel setzen
Legen Sie fest, zu welchem Kurs Sie kaufen würden. Wir helfen Ihnen, bereit zu bleiben.
Basierend auf
Sicherheitsmarge
0%
10%
20%
30%
40%
50%
Ihr Kursziel
Verknüpft mit
aktuellem Kurs
· In Kaufzone
Lädt
Notiz verknüpft
Wählen Sie die Aktie, die Sie mit einem Kursziel beobachten möchten
Zuletzt angesehen
|
Relmada Therapeutics Inc
F:4E2
|
US |
|
N
|
Nebius Group NV
XMUN:YDX
|
NL |
|
GATX Corp
NYSE:GATX
|
US |
|
I
|
Interface Inc
XBER:IF6N
|
US |
|
Equinor ASA
F:DNQA
|
NO |
|
S
|
Swedish Match AB
F:SWMC
|
SE |
|
C
|
Cyberark Software Ltd
F:CYB
|
IL |
Gewinn- und Verlustrechnung
Ergebnis-Wasserfall
Relmada Therapeutics Inc
Relmada Therapeutics Inc
Gewinn- und Verlustrechnung
Relmada Therapeutics Inc
Relmada Therapeutics Inc
Währung: USD
| Aug-2012 | Nov-2012 | Feb-2013 | May-2013 | Aug-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Umsatz | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Zinsaufwand |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Umsatz |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Bruttogewinn | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Umsatzkosten |
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Bruttogewinn |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operatives Ergebnis | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Operative Kosten |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(13)
|
(17)
|
(21)
|
(25)
|
(17)
|
(18)
|
(19)
|
(18)
|
(16)
|
(13)
|
(9)
|
(9)
|
(7)
|
(6)
|
(6)
|
(7)
|
(7)
|
(8)
|
(10)
|
(11)
|
(13)
|
(18)
|
(15)
|
(22)
|
(31)
|
(44)
|
(61)
|
(73)
|
(87)
|
(112)
|
(126)
|
(142)
|
(161)
|
(157)
|
(161)
|
(151)
|
(132)
|
(116)
|
(104)
|
(99)
|
(92)
|
(92)
|
(84)
|
(79)
|
(71)
|
(58)
|
(59)
|
|
| Vertriebs-, Verwaltungs- und Gemeinkosten |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(12)
|
(15)
|
(17)
|
(19)
|
(9)
|
(8)
|
(9)
|
(9)
|
(10)
|
(9)
|
(7)
|
(7)
|
(6)
|
(5)
|
(6)
|
(5)
|
(4)
|
(4)
|
(5)
|
(6)
|
(6)
|
(7)
|
(7)
|
(11)
|
(18)
|
(22)
|
(25)
|
(28)
|
(29)
|
(32)
|
(35)
|
(40)
|
(45)
|
(45)
|
(48)
|
(47)
|
(45)
|
(49)
|
(49)
|
(46)
|
(42)
|
(42)
|
(38)
|
(34)
|
(34)
|
(28)
|
(32)
|
|
| F&E |
0
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(2)
|
(4)
|
(6)
|
(8)
|
(10)
|
(10)
|
(8)
|
(6)
|
(4)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(2)
|
(3)
|
(4)
|
(5)
|
(5)
|
(7)
|
(8)
|
(8)
|
(11)
|
(13)
|
(23)
|
(36)
|
(45)
|
(57)
|
(80)
|
(91)
|
(102)
|
(115)
|
(112)
|
(113)
|
(104)
|
(87)
|
(67)
|
(55)
|
(52)
|
(49)
|
(50)
|
(46)
|
(45)
|
(37)
|
(30)
|
(27)
|
|
| Sonstige operative Kosten |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(4)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operatives Ergebnis |
(0)
N/A
|
(0)
-100%
|
(0)
N/A
|
(0)
-100%
|
(0)
-25%
|
(1)
-1.380%
|
(13)
-1.650%
|
(17)
-29%
|
(21)
-26%
|
(25)
-18%
|
(17)
+31%
|
(18)
-5%
|
(19)
-7%
|
(18)
+9%
|
(16)
+7%
|
(13)
+19%
|
(9)
+32%
|
(9)
+5%
|
(7)
+15%
|
(6)
+10%
|
(6)
+1%
|
(7)
-4%
|
(7)
-4%
|
(8)
-21%
|
(10)
-24%
|
(11)
-1%
|
(13)
-21%
|
(18)
-40%
|
(15)
+15%
|
(22)
-48%
|
(31)
-39%
|
(44)
-43%
|
(61)
-37%
|
(73)
-20%
|
(87)
-19%
|
(112)
-29%
|
(126)
-12%
|
(142)
-13%
|
(161)
-13%
|
(157)
+2%
|
(161)
-3%
|
(151)
+6%
|
(132)
+13%
|
(116)
+12%
|
(104)
+10%
|
(99)
+5%
|
(92)
+7%
|
(92)
0%
|
(84)
+9%
|
(79)
+5%
|
(71)
+11%
|
(58)
+18%
|
(59)
-2%
|
|
| Ergebnis vor Steuern | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Zinserträge/-aufwendungen |
0
|
0
|
0
|
0
|
0
|
7
|
(8)
|
(35)
|
(25)
|
(30)
|
(4)
|
32
|
25
|
24
|
13
|
4
|
1
|
0
|
1
|
1
|
0
|
(1)
|
(2)
|
(3)
|
(3)
|
(2)
|
(1)
|
0
|
0
|
(1)
|
1
|
1
|
1
|
2
|
1
|
0
|
(0)
|
(2)
|
(2)
|
(3)
|
(2)
|
1
|
3
|
4
|
5
|
4
|
5
|
5
|
4
|
3
|
3
|
2
|
2
|
|
| Nicht wiederkehrende Posten |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(4)
|
(4)
|
(4)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Gewinn/Verlust aus Anlagenabgängen |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Sonstige Erträge gesamt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
6
|
6
|
6
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Vorsteuergewinn |
(0)
N/A
|
(0)
-100%
|
(0)
N/A
|
(0)
-100%
|
(0)
-25%
|
6
N/A
|
(21)
N/A
|
(51)
-140%
|
(46)
+11%
|
(55)
-20%
|
(21)
+62%
|
14
N/A
|
6
-58%
|
6
+10%
|
(3)
N/A
|
(9)
-212%
|
(8)
+15%
|
(8)
-2%
|
(6)
+21%
|
(6)
+11%
|
(6)
-7%
|
(7)
-20%
|
(9)
-24%
|
(11)
-27%
|
(17)
-50%
|
(17)
+3%
|
(17)
-5%
|
(18)
-2%
|
(15)
+15%
|
(23)
-53%
|
(30)
-30%
|
(43)
-44%
|
(59)
-38%
|
(71)
-19%
|
(86)
-22%
|
(112)
-30%
|
(126)
-12%
|
(143)
-14%
|
(157)
-9%
|
(153)
+2%
|
(157)
-2%
|
(144)
+9%
|
(129)
+10%
|
(112)
+14%
|
(99)
+11%
|
(94)
+5%
|
(87)
+8%
|
(87)
N/A
|
(80)
+8%
|
(76)
+5%
|
(68)
+11%
|
(56)
+17%
|
(57)
-2%
|
|
| Nettogewinn | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Steueraufwand |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Ergebnis aus fortgeführten Geschäftsbereichen |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
6
|
(21)
|
(51)
|
(46)
|
(55)
|
(21)
|
14
|
6
|
6
|
(3)
|
(9)
|
(8)
|
(8)
|
(6)
|
(6)
|
(6)
|
(7)
|
(9)
|
(11)
|
(17)
|
(17)
|
(17)
|
(18)
|
(15)
|
(23)
|
(30)
|
(43)
|
(59)
|
(71)
|
(86)
|
(112)
|
(126)
|
(143)
|
(157)
|
(153)
|
(157)
|
(144)
|
(129)
|
(112)
|
(99)
|
(94)
|
(87)
|
(87)
|
(80)
|
(76)
|
(68)
|
(56)
|
(57)
|
|
| Nettogewinn |
(0)
N/A
|
(0)
-100%
|
(0)
N/A
|
(0)
-100%
|
(0)
-25%
|
6
N/A
|
(21)
N/A
|
(51)
-140%
|
(46)
+11%
|
(55)
-20%
|
(21)
+62%
|
14
N/A
|
6
-58%
|
6
+10%
|
(3)
N/A
|
(9)
-212%
|
(8)
+15%
|
(8)
-2%
|
(6)
+21%
|
(6)
+11%
|
(6)
-7%
|
(7)
-20%
|
(9)
-24%
|
(11)
-27%
|
(17)
-50%
|
(17)
+3%
|
(17)
-5%
|
(18)
-2%
|
(15)
+15%
|
(23)
-53%
|
(30)
-30%
|
(43)
-44%
|
(59)
-38%
|
(71)
-19%
|
(86)
-22%
|
(112)
-30%
|
(126)
-12%
|
(143)
-14%
|
(157)
-9%
|
(153)
+2%
|
(157)
-2%
|
(144)
+9%
|
(129)
+10%
|
(112)
+14%
|
(99)
+11%
|
(94)
+5%
|
(87)
+8%
|
(87)
N/A
|
(80)
+8%
|
(76)
+5%
|
(68)
+11%
|
(56)
+17%
|
(57)
-2%
|
|
| Verwässertes EPS |
-0,01
N/A
|
-0,02
-100%
|
-0,02
N/A
|
-0,04
-100%
|
-0,04
N/A
|
2,58
N/A
|
-34,43
N/A
|
-25,08
+27%
|
-12,98
+48%
|
-20,39
-57%
|
-8,37
+59%
|
4,24
N/A
|
2,02
-52%
|
2,12
+5%
|
-1,03
N/A
|
-3,08
-199%
|
-2,61
+15%
|
-2,65
-2%
|
-2,08
+22%
|
-1,79
+14%
|
-1,91
-7%
|
-2,3
-20%
|
-2,86
-24%
|
-3,63
-27%
|
-2,66
+27%
|
-2,2
+17%
|
-2,74
-25%
|
-1,8
+34%
|
-1,47
+18%
|
-1,55
-5%
|
-1,95
-26%
|
-2,69
-38%
|
-3,81
-42%
|
-4,28
-12%
|
-5,06
-18%
|
-6,41
-27%
|
-7,16
-12%
|
-5,04
+30%
|
-5,23
-4%
|
-5,1
+2%
|
-5,3
-4%
|
-4,77
+10%
|
-4,28
+10%
|
-3,7
+14%
|
-3,28
+11%
|
-3,13
+5%
|
-2,88
+8%
|
-2,89
0%
|
-2,65
+8%
|
-2,51
+5%
|
-2,05
+18%
|
-1,69
+18%
|
-1,45
+14%
|
|
Wechseln zu:
Wechseln zu:
Auch interessant
Other Relmada Therapeutics Inc listings:
Mehr entdecken
